Literature DB >> 26521094

Curcumin as an Adjunct Drug for Infectious Diseases.

Govindarajan Padmanaban1, Pundi N Rangarajan2.   

Abstract

Curcumin, by virtue of its ability to function as an immunomodulator, has the potential to serve as an adjunct drug to treat infectious diseases and provide long-term protection. The current need is to establish clinical trials with curcumin as an adjunct drug against specific infectious diseases.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  clinical trials; curcumin; drugs; infectious diseases; malaria

Mesh：

Substances：

Year:  2015        PMID： 26521094     DOI： 10.1016/j.tips.2015.09.007

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN： 0165-6147            Impact factor:   14.819


  8 in total

1.  Evaluation of the Efficacy of Curcumin in the Treatment of Oral Lichen Planus: A Randomized Controlled Trial.

Authors:  Maryam Amirchaghmaghi; Atessa Pakfetrat; Zahra Delavarian; Hanieh Ghalavani; Ala Ghazi
Journal:  J Clin Diagn Res       Date:  2016-05-01

2.  Curcumin May Defy Medicinal Chemists.

Authors:  Govindarajan Padmanaban; Viswanathan A Nagaraj
Journal:  ACS Med Chem Lett       Date:  2017-02-15       Impact factor: 4.345

3.  Curcumin-loaded graphene oxide flakes as an effective antibacterial system against methicillin-resistant Staphylococcus aureus.

Authors:  F Bugli; M Cacaci; V Palmieri; R Di Santo; R Torelli; G Ciasca; M Di Vito; A Vitali; C Conti; M Sanguinetti; M De Spirito; M Papi
Journal:  Interface Focus       Date:  2018-04-20       Impact factor: 3.906

4.  Isolation and Structural Characterization of Bioactive Molecules on Prostate Cancer from Mayan Traditional Medicinal Plants.

Authors:  Rafael Sebastián Fort; Juan M Trinidad Barnech; Juliette Dourron; Marcos Colazzo; Francisco J Aguirre-Crespo; María Ana Duhagon; Guzmán Álvarez
Journal:  Pharmaceuticals (Basel)       Date:  2018-08-14

Review 5.  Antiviral and immunomodulatory activity of curcumin: A case for prophylactic therapy for COVID-19.

Authors:  Rajesh K Thimmulappa; Kiran Kumar Mudnakudu-Nagaraju; Chandan Shivamallu; K J Thirumalai Subramaniam; Arun Radhakrishnan; Suresh Bhojraj; Gowthamarajan Kuppusamy
Journal:  Heliyon       Date:  2021-02-22

6.  Oral Co-Supplementation of Curcumin, Quercetin, and Vitamin D3 as an Adjuvant Therapy for Mild to Moderate Symptoms of COVID-19-Results From a Pilot Open-Label, Randomized Controlled Trial.

Authors:  Amjad Khan; Somia Iqtadar; Sami Ullah Mumtaz; Michael Heinrich; Domingo A Pascual-Figal; Shona Livingstone; Sajid Abaidullah
Journal:  Front Pharmacol       Date:  2022-06-07       Impact factor: 5.988

7.  Nanocurcumin is superior to native curcumin in preventing degenerative changes in Experimental Cerebral Malaria.

Authors:  Chaitanya Dende; Jairam Meena; Perumal Nagarajan; Viswanathan Arun Nagaraj; Amulya Kumar Panda; Govindarajan Padmanaban
Journal:  Sci Rep       Date:  2017-08-30       Impact factor: 4.379

8.  Injectable Nanocurcumin-Formulated Chitosan-g-Pluronic Hydrogel Exhibiting a Great Potential for Burn Treatment.

Authors:  Le Hang Dang; Thi Hiep Nguyen; Ha Le Bao Tran; Vu Nguyen Doan; Ngoc Quyen Tran
Journal:  J Healthc Eng       Date:  2018-05-13       Impact factor: 2.682
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.